Everything you need to pursue ACR® Stereotactic Breast Biopsy Accreditation
ACR Accreditation is a valuable tool for maintaining excellence in everything from operations to patient care. To prepare for your application:
Once you’ve applied and received your testing materials, the following documents can help you navigate the next steps to ACR Accreditation.
See the complete breakout of pricing by units, modules and sites including multiple modality discounts.
Stay up to date on the latest accreditation program news.
The American College of Radiology®, with leadership and guidance from the ACR Commission on Breast Imaging, offers information for breast imaging physicians and their practices to mitigate patient care disruptions tied to a long-term shortage of stereotactic breast biopsy needles.
Effective Jan. 1, 2026, all phantom exams for CT, MR, NM/PET, and stereotactic breast biopsy accreditation must be performed within 14 months of the testing package release date. Facilities may use images from the most recent annual medical physicist survey if they meet all requirements. Images older than 14 months before the package date will not be accepted.
ACR Accreditation now offers non-U.S. imaging facilities recognition for meeting current ACR accreditation standards. Facilities will submit self-assessment documentation for verification. No clinical or phantom images required.
